Sugi Predict

Sugi Predict / Compounds / SCHEMBL2585556

SCHEMBL2585556

SCHEMBL2585556

COc1ccc(OC)c(NCl)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.62
▸ MAPT P10636 6/20 0.62
▸ GAA P10253 5/20 0.62
▸ MEN1 O00255 5/20 0.62
▸ LMNA P02545 2/20 0.62
▸ USP2 O75604 1/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ CA12 O43570 1/20 0.56
▸ CA1 P00915 1/20 0.56
▸ CA2 P00918 1/20 0.56
▸ CA7 P43166 1/20 0.56
▸ CA9 Q16790 1/20 0.56
▸ CA14 Q9ULX7 1/20 0.56
▸ TP53 P04637 2/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ POLB P06746 3/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ THRB P10828 1/20 0.48
▸ HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16843457 0.83 GAA (0.47) KMT2AMAPTGAAMEN1LMNA
SCHEMBL3397530 0.82 KMT2A (0.47) KMT2AMAPTGAAMEN1LMNA
SCHEMBL1576523 0.81 GAA (0.59) KMT2AMAPTGAAMEN1LMNA
SCHEMBL18500628 0.79 KMT2A (0.58) KMT2AMAPTGAAMEN1LMNA
SCHEMBL15764263 0.79 TDP1 (0.53) KMT2AMAPTGAAMEN1LMNA
SCHEMBL19155568 0.79 KMT2A (0.58) KMT2AMAPTGAAMEN1LMNA
SCHEMBL17705666 0.79 KMT2A (0.58) KMT2AMAPTGAAMEN1LMNA
SCHEMBL28683525 0.79 KMT2A (0.58) KMT2AMAPTGAAMEN1LMNA
SCHEMBL2091173 0.79 KMT2A (0.58) KMT2AMAPTGAAMEN1LMNA
Bromide SCHEMBL20984992 0.78 KMT2A (0.56) KMT2AMAPTGAAMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106588685-A Preparation method of 4-Chloro-2,5-dimethoxyacetoace tanilide 南通醋酸化工股份有限公司 2017-04-26 — — CN claimed
CN-104119247-B A kind of preparation method of 4 chlorine, 2,5 dimethoxy AAA 响水恒利达科技化工有限公司 2017-04-05 — — CN claimed
CN-106588685-B 2,5- of one kind dimethoxy-4 '-chloracetyl antifebrin preparation method 南通醋酸化工股份有限公司 2019-03-01 — — CN disclosed
CN-105601523-B A kind of method for synthesizing the chloroaniline of 2,5 dimethoxy 4 辽宁大学 2018-03-13 — — CN disclosed
CN-105461583-B The preparation of new azoic coupling component AS LC a kind of and processing technology 常熟市柏伦精细化工有限公司 2017-09-05 — — CN disclosed
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 — — CN disclosed
CN-106588685-A Preparation method of 4-Chloro-2,5-dimethoxyacetoace tanilide 南通醋酸化工股份有限公司 2017-04-26 — — CN disclosed
CN-105143353-B Disazo pigment composition and method for producing same 东洋油墨SC控股株式会社 2017-03-15 — — CN disclosed
CN-104557574-B Method for preparing 2, 5-dimethoxy-4-chloroaniline 中国石油化工股份有限公司 2017-03-01 — — CN disclosed
CN-106045864-A Production process for preparing 4-chloro-2,5-dimethoxyaniline with hydrazine hydrate catalytic reduction method 洛阳卓特化工有限公司 2016-10-26 — — CN disclosed
CN-105949069-A Method for continuous hydrogenation production of 4-chloro-2,5-dimethoxyaniline 济南和润化工科技有限公司 2016-09-21 — — CN disclosed
US-20130274298-A1 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS FUNDACAO OSWALDO CRUZ (BR) 2013-10-17 — — US disclosed
US-8436027-B2 Azole compounds used as tuberculostatic and leishmanicide agents Fundacão Oswaldo Cruz—FIOCRUZ (BR) 2013-05-07 — — US disclosed
US-20110269803-A1 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS FUNDACAO OSWALDO CRUZ - FIOCRUZ (BR) 2011-11-03 — — US disclosed
US-20090054501-A1 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS BOECHAT NUBIA 2009-02-26 — — US disclosed
EP-1976832-A2 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS Fundacao Oswaldo Cruz - Fiocruz (BR) 2008-10-08 — — EP disclosed
WO-2007019660-A2 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS Fundação Oswaldo Cruz - FIOCRUZ (BR) 2007-02-22 — — WO disclosed
EP-0347796-B1 PREPARATION PROCESS OF 4-CHLORO-2,5-DIMETHOXY-ANILINE HOECHST AKTIENGESELLSCHAFT (DE) 1993-08-04 — — EP disclosed
US-5041671-A Process for the preparation 4-chloro-2,5-dimethoxy-aniline HOECHST AKTIENGESELLSCHAFT (DE) 1991-08-20 — — US disclosed
EP-0347796-A2 Preparation process of 4-chloro-2,5-dimethoxy-aniline HOECHST AKTIENGESELLSCHAFT (DE) 1989-12-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274298-A1 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS CYP51A1, IPO5, TBC1D5 KMT2A 3111/4885MAPT 1794/4885GAA 64/4885
US-20090054501-A1 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS CBR3, NOX3, NR2C2 KMT2A 3726/4885MAPT 4759/4885GAA 3120/4885
US-20110269803-A1 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS CBR3, NOX3, NR2C2 KMT2A 3686/4885MAPT 4785/4885GAA 3013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.